Immune Cell Populations in the Endometrium

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
Age18-45
SponsorJagiellonian University

About this trial

Specialized immunological studies in the diagnostics of idiopathic infertility and recurrent miscarriages have limited applicability, as the role of the immune system in these conditions is not thoroughly understood. In ovulatory cycles, changes occur in the populations of uterine lymphocytes, which may influence the receptivity of the endometrium and the implantation of the embryo. Particularly notable are the changes in natural killer (NK) cells, which reach their peak during the luteal phase and regulate the invasion of the trophoblast. The dominant NK cells exhibit a CD56bright phenotype and differ in cytokine profiles from peripheral blood cells. Cyclical changes also affect macrophages and T lymphocytes; however, it is unclear whether their proportions differ in women with reduced fertility. There is a need to investigate how the composition of lymphocytes in blood influences the populations in the endometrium. The aim of this study is to analyze the correlation between peripheral and endometrial lymphocytes in women with idiopathic infertility and recurrent miscarriages, compared to fertile women.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

age 18-45 years

idiopathic infertility

at least 2 miscarriages

other benign gynecological conditions subjected to endometrial sampling

Disqualifiers

miscarriage within last 3 months

abdominal/uterine surgery within last 3 months

viral/bacterial infection within last 3 months

antibiotic therapy within last 3 months

Trial population

Women undergoing endometrial aspiration biopsy for the diagnosis of: i) idiopathic infertility, ii) recurrent miscarriages, iii) other conditions requiring histopathological examination of the endometrium (control).

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

  • Percentage distribution of immune system cells in peripheral blood

    Diagnostic test

    Assessment of the percentage distribution of the immune system cell population in peripheral blood by flow cytometry

  • Percentage distribution of immune system cells in endometrium

    Diagnostic test

    Assessment of the percentage distribution of the immune system cell population in endometrium by flow cytometry

Treatment groups

50 Participants
are divided into 2 treatment groups
Group A: Infertility2 interventions
Group B: Normal fertility2 interventions

Trial outcomes

Primary outcomes

1

Assessment of the percentage of Non-classical monocytes CD16++/ CD14- (% monocytes) in peripheral blood

Comparison of the percentage of Non-classical monocytes CD16++/ CD14- (% monocytes) in both study arms - in the group with normal and reduced fertility

Time frame
up to 6 months
2

Assessment of the percentage of Intermediate monocytes CD16+/CD14+ (% monocytes) in peripheral blood by flow cytometry

Comparison of the percentage of Intermediate monocytes CD16+/CD14+ (% monocytes) in both study arms - in the group with normal and reduced fertility

Time frame
up to 6 months
3

Assessment of the percentage of Classical monocytes CD16-/CD14++ (% monocytes) in peripheral blood by flow cytometry

Comparison of the percentage of Classical monocytes CD16-/CD14++ (% monocytes) in both study arms - in the group with normal and reduced fertility

Time frame
up to 6 months
4

Assessment of the percentage of plasmocytes (% leukocytes) in peripheral blood by flow cytometry

Comparison of the percentage of plasmocytes (% leukocytes) in both study arms - in the group with normal and reduced fertility

Time frame
up to 6 months

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.